초음파 시장 2026년까지의 세계 예측

출판: MarketsandMarkets(마켓츠앤드마켓츠)출판년월:2022년01월

・기술(진단(2D, 3D, 도플러), 치료(HIFU, ESWL)), 디스플레이(컬러, 흑백), 휴대성(트롤리, POC), 용도(부인과, 심장병학, 정형외과), 구성요소(프로브 ), 최종 사용자(병원) – 2026년까지의 세계 예측

Ultrasound Market by Technology (Diagnostic (2D, 3D, Doppler), Therapeutic (HIFU, ESWL)), Display (Color, B&W), Portability (Trolley, POC), Application (Gynecology, Cardiology, Orthopedic), Component (Probe), End user (Hospitals) – Global Forecasts to 2026

폐이지수 270
도표수 247
가격
Single User License USD7,150
Multi User License(5명) USD8,500
Corporate(site) License USD9,650
Enterprise License USD11,000
구성 영문조사보고서

리포트목차보기    견적・문의・의뢰로 이동    구입안내

Sample Request

The global ultrasound market is projected to reach USD 9.0 billion by 2026 from USD 6.7 billion in 2021, at a CAGR of 6.3% during the forecast period. Growth of the market is mainly attributed to the technological advancements; increasing incidences of target diseases; rising patient preference for minimally invasive procedures; and growing public and private investments, funding, and grants are driving the growth of the global ultrasound market. However, stringent government regulations may restrict the growth of this market to a certain extent in the coming years.
세계 초음파 시장은 예측 기간 동안 6.3%의 CAGR로 2021년 67억 달러에서 2026년 90억 달러에 이를 것으로 예상됩니다. 시장의 성장은 주로 기술 발전에 기인합니다. 표적 질환의 발병률 증가; 최소 침습 절차에 대한 환자 선호도 증가; 증가하는 공공 및 민간 투자, 자금 조달 및 보조금이 글로벌 초음파 시장의 성장을 주도하고 있습니다.

“therapeutic ultrasound technology segment to register significant growth, during the forecast period”

On the basis of technology, the ultrasound market is segmented into diagnostic ultrasound and therapeutic ultrasound devices. The therapeutic ultrasound segment is expected to grow at a significant rate over the forecast period. Therapeutic ultrasound technologies include focused ultrasound and shockwave lithotripsy. The growth of this market is driven mainly by ongoing technological innovations in the field of focused ultrasound as well as the expansion of its application horizons.

“Color ultrasound devices segment is expected to witness the highest growth in the ultrasound market, by device display, during the forecast period”

On the basis of device display, the ultrasound market is segmented into black & white ultrasound and color ultrasound devices. The color ultrasound devices segment is expected to grow at the highest CAGR during the forecast period owing to the benefits offered by these devices, such as better image quality and higher image resolution. Also, the growing availability of advanced color ultrasound devices, coupled with the continuous decline in product cost across major countries and expanding distribution networks of major manufacturers across emerging countries, are expected to support the growth of this market segment during the forecast period.

“Trolley/cart-based ultrasound systems segment is expected to account for the largest share of the ultrasound market, by system portability”
Based on system portability, the ultrasound market is segmented into trolley/cart-based ultrasound systems, compact/handheld ultrasound systems, and point-of-care (PoC) ultrasound systems. In 2020, the trolley/cart-based ultrasound systems segment is expected to account for the largest market share due to the growing adoption of these systems across major markets (as a result of their increasing use in emergency care and acute care settings in hospitals and healthcare institutions).

“Transducers/ Probes segment is expected to account for the largest share in the Component segment in 2021”
On the basis of component, the ultrasound market is segmented into transducers/probes, workstations, and other components. The transducers/probes segment is further divided into curvilinear/convex array probes, liner array probes, phased array probes, and other probes. The transducers/probes segment accounted for the largest share of the ultrasound market in 2020. This can be attributed to technological advancements, the introduction of specially designed products, and the rising adoption of ultrasound technology for the diagnosis of various disease indications.

“Asia Pacific market is expected to grow at the highest CAGR during the forecast period”
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period majorly due to the increasing healthcare expenditure across the region’s major countries (especially India and China), growing public awareness about the therapeutic potential of ultrasound technologies, continuous decrease in device costs (due to growing localized manufacturing and the presence of global market players), rising prevalence of target diseases, and the ongoing trend of device miniaturization.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3– 21%
• By Designation: C-level–47%, Director-level–33%, and Others–20%
• By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%

In 2020, the ultrasound market was dominated by GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Hitachi, Ltd. (Japan), and Siemens Healthineers AG (Germany).

Research Coverage

This report studies the ultrasound market based on technology, device display, system portability, application, component, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the ultrasound market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the ultrasound market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the ultrasound market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.


목차

1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS & EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY USED FOR THE STUDY 35
1.5 MARKET STAKEHOLDERS 35
1.6 LIMITATIONS 36
1.7 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
FIGURE 1 RESEARCH DESIGN 37
2.1.1 SECONDARY DATA 38
2.1.1.1 Secondary sources 39
2.1.2 PRIMARY DATA 39
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40
2.2 MARKET ESTIMATION METHODOLOGY 40
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 41
2.2.1 VENDOR REVENUE-BASED MARKET SIZE ESTIMATION 41
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 42
2.2.2 END USER-BASED MARKET SIZE ESTIMATION 42
FIGURE 5 ULTRASOUND MARKET: END USER-BASED ESTIMATION 43
2.2.3 PRIMARY RESEARCH VALIDATION 43
2.3 COVID-19 HEALTH ASSESSMENT 43
2.4 COVID-19 ECONOMIC ASSESSMENT 44
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 44
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY 44
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 45
2.6 DATA TRIANGULATION 46
FIGURE 8 DATA TRIANGULATION METHODOLOGY 46
2.7 RESEARCH ASSUMPTIONS 47
2.8 RESEARCH LIMITATIONS 47

3 EXECUTIVE SUMMARY 48
FIGURE 9 ULTRASOUND MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION) 48
FIGURE 10 ULTRASOUND MARKET SHARE, BY DISPLAY TYPE, 2021 VS. 2026 49
FIGURE 11 ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2021 VS. 2026 (USD MILLION) 49
FIGURE 12 ULTRASOUND MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 50
FIGURE 13 ULTRASOUND MARKET SHARE, BY END USER, 2021 VS. 2026 51
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE ULTRASOUND MARKET 52
4 PREMIUM INSIGHTS 53
4.1 ULTRASOUND MARKET OVERVIEW 53
FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE THE GROWTH OF THE ULTRASOUND MARKET 53
4.2 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE AND COUNTRY 54
FIGURE 16 GERMANY IS THE LARGEST MARKET FOR DIAGNOSTIC ULTRASOUND IN EUROPE 54
4.3 ULTRASOUND MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 55
FIGURE 17 VASCULAR APPLICATIONS SEGMENT TO REGISTER SUBSTANTIAL GROWTH IN THE GLOBAL ULTRASOUND MARKET 55
4.4 GEOGRAPHIC SNAPSHOT OF THE ULTRASOUND MARKET 55
FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 19 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
5.2.1 DRIVERS 57
5.2.1.1 Increasing prevalence of target diseases 57
5.2.1.2 Rising patient preference for minimally invasive procedures 57
5.2.1.3 Technological advancements 58
TABLE 1 RECENT PRODUCT LAUNCHES/APPROVALS IN THE ULTRASOUND MARKET 58
5.2.1.4 Growing public and private investments, funding, and grants 59
5.2.1.5 Increasing number of diagnostic centers & hospitals 59
5.2.2 RESTRAINTS 60
5.2.2.1 Unfavorable healthcare reforms in the US 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Expanding applications of therapeutic ultrasound 60
5.2.3.2 Emerging markets 61
5.2.3.3 Development of POC ultrasound devices 61
5.2.4 CHALLENGES 62
5.2.4.1 Growing end-user preference for refurbished equipment 62
5.2.4.2 Dearth of skilled and well-trained sonographers 62
5.3 INDUSTRY TRENDS 62
5.3.1 DEVELOPMENT OF APPLICATION-SPECIFIC ULTRASOUND DEVICES 62
5.3.2 GROWING USE OF ULTRASOUND IN ELASTOGRAPHY 63
5.3.3 INCREASING USE OF MR-GUIDED ULTRASOUND MODALITIES IN NEUROLOGY APPLICATIONS 63
5.4 PRICING TREND ANALYSIS (2017–2020) 64
5.4.1 NORTH AMERICA 64
5.4.2 EUROPE 64
5.4.3 ASIA PACIFIC 65
5.4.4 REST OF THE WORLD 65
5.5 VALUE CHAIN ANALYSIS 66
FIGURE 20 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE 66
5.6 REGULATORY ANALYSIS 67
5.6.1 NORTH AMERICA 67
5.6.1.1 US 67
TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION 67
TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
5.6.1.2 Canada 68
TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 69
5.6.2 EUROPE 70
FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 71
5.6.3 ASIA PACIFIC 72
5.6.3.1 Japan 72
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 72
5.6.3.2 China 73
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES 73
5.6.3.3 India 74
5.7 PORTER’S FIVE FORCES ANALYSIS 75
TABLE 7 ULTRASOUND MARKET: PORTER’S FIVE FORCES ANALYSIS 75
5.7.1 THREAT OF NEW ENTRANTS 75
5.7.2 THREAT OF SUBSTITUTES 75
5.7.3 BARGAINING POWER OF SUPPLIERS 76
5.7.4 BARGAINING POWER OF BUYERS 76
5.7.5 DEGREE OF COMPETITION 76
5.8 COVID-19 IMPACT ON THE ULTRASOUND MARKET 76
5.9 ECOSYSTEM COVERAGE: ULTRASOUND MARKET 78
5.10 PATENT ANALYSIS 79
FIGURE 23 TOP 10 PATENT APPLICANTS FOR ULTRASOUND (DECEMBER 2021) 79
FIGURE 24 PATENT APPLICATIONS FOR ULTRASOUND
(JANUARY 2011 TO DECEMBER 2021) 79
FIGURE 25 TOP 10 PATENT APPLICANTS FOR THERAPEUTIC ULTRASOUND
(JANUARY 2011 TO AUGUST 2021) 80
FIGURE 26 PATENT APPLICATIONS FOR THERAPEUTIC ULTRASOUND
(JANUARY 2011 TO DECEMBER 2021) 80
FIGURE 27 TOP 10 PATENT APPLICANTS FOR POINT-OF-CARE ULTRASOUND
(JANUARY 2011 TO AUGUST 2021) 81
FIGURE 28 PATENT APPLICATIONS FOR POINT-OF-CARE ULTRASOUND
(JANUARY 2011 TO DECEMBER 2021) 81
5.11 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS 82
TABLE 8 IMPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION) 82
TABLE 9 EXPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION) 82
6 ULTRASOUND MARKET, BY TECHNOLOGY 83
6.1 INTRODUCTION 84
TABLE 10 ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 84
6.2 DIAGNOSTIC ULTRASOUND 84
TABLE 11 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019–2026 (USD MILLION) 84
TABLE 12 DIAGNOSTIC ULTRASOUND MARKET, BY REGION,
2019–2026 (USD MILLION) 85
6.2.1 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 85
TABLE 13 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 85
6.2.2 DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 86
TABLE 14 DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 86
6.2.3 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 86
TABLE 15 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 86
6.2.4 DIAGNOSTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 87
TABLE 16 DIAGNOSTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 87
6.2.5 2D ULTRASOUND 87
6.2.5.1 Strong market demand from less-developed and emerging countries to sustain the growth of this segment 87
TABLE 17 2D ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 88
6.2.6 2D ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 88
TABLE 18 2D ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 88
6.2.7 2D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 89
TABLE 19 2D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 89
6.2.8 2D ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 89
TABLE 20 2D ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 89
6.2.9 2D ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 90
TABLE 21 2D ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 90
6.2.10 3D AND 4D ULTRASOUND 90
6.2.10.1 Greater diagnostic accuracy and improved imaging capabilities to boost the global market demand for 3D/4D ultrasound 90
TABLE 22 3D AND 4D ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 91
6.2.11 3D AND 4D ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 91
TABLE 23 3D AND 4D ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 91
6.2.12 3D AND 4D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 92
TABLE 24 3D AND 4D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 92
6.2.13 3D AND 4D ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 92
TABLE 25 3D AND 4D ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 92
6.2.14 3D AND 4D ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 93
TABLE 26 3D AND 4D ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 93
6.2.15 DOPPLER ULTRASOUND 93
6.2.15.1 Growing application in pain management, cardiovascular imaging, and emergency care to drive market growth 93
TABLE 27 DOPPLER ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 94
6.2.16 DOPPLER ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 94
TABLE 28 DOPPLER ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 94
6.2.17 DOPPLER ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 95
TABLE 29 DOPPLER ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 95
6.2.18 DOPPLER ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 95
TABLE 30 DOPPLER ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 95
6.2.19 DOPPLER ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 96
TABLE 31 DOPPLER ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 96
6.3 THERAPEUTIC ULTRASOUND 96
TABLE 32 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019–2026 (USD MILLION) 96
TABLE 33 THERAPEUTIC ULTRASOUND MARKET, BY REGION,
2019–2026 (USD MILLION) 97
6.3.1 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 97
TABLE 34 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 97
6.3.2 THERAPEUTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 98
TABLE 35 THERAPEUTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 98
6.3.3 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 98
TABLE 36 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 98
6.3.4 THERAPEUTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 99
TABLE 37 THERAPEUTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 99
6.3.5 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY 99
6.3.5.1 Growing emphasis on the minimally invasive treatment of kidney and gall bladder stones to drive the demand for ESWL 99
TABLE 38 ESWL ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 100
6.3.6 ESWL ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 100
TABLE 39 ESWL ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 100
6.3.7 ESWL ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 101
TABLE 40 ESWL ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 101
6.3.8 ESWL ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 101
TABLE 41 ESWL ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 101
6.3.9 ESWL ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 102
TABLE 42 ESWL ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 102
6.3.10 HIGH-INTENSITY FOCUSED ULTRASOUND 102
6.3.10.1 Promising results associated with HIFU for the treatment of various cancers to drive market growth 102
TABLE 43 HIFU ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 103
6.3.11 HIFU ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 103
TABLE 44 HIFU ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 103
6.3.12 HIFU ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 104
TABLE 45 HIFU ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 104
6.3.13 HIFU ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 104
TABLE 46 HIFU ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 104
6.3.14 HIFU ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 105
TABLE 47 HIFU ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 105

7 ULTRASOUND MARKET, BY SYSTEM PORTABILITY 106
7.1 INTRODUCTION 107
TABLE 48 ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 107
7.2 TROLLEY/CART-BASED DEVICES 107
7.2.1 INCREASED USE OF TROLLEY-BASED SYSTEMS FOR ACUTE CARE & EMERGENCY CARE TO DRIVE MARKET GROWTH 107
TABLE 49 ULTRASOUND MARKET FOR TROLLEY/CART-BASED DEVICES, BY REGION, 2019–2026 (USD MILLION) 108
7.3 COMPACT/TABLE-TOP DEVICES 108
7.3.1 DEVICE AFFORDABILITY AS WELL AS PROCEDURAL & TECHNICAL BENEFITS TO DRIVE THE DEMAND FOR TABLE-TOP DEVICES 108
TABLE 50 ULTRASOUND MARKET FOR COMPACT/TABLE-TOP DEVICES, BY REGION, 2019–2026 (USD MILLION) 109
7.4 POC/PORTABLE DEVICES 109
7.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST THE DEMAND FOR POC ULTRASOUND DEVICES 109
TABLE 51 ULTRASOUND MARKET FOR POC/PORTABLE DEVICES, BY REGION,
2019–2026 (USD MILLION) 110
8 ULTRASOUND MARKET, BY DISPLAY TYPE 111
8.1 INTRODUCTION 112
TABLE 52 ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 112
8.2 COLOR ULTRASOUND DEVICES 112
8.2.1 GREATER MARKET AVAILABILITY OF ADVANCED COLOR ULTRASOUND DEVICES TO DRIVE THE MARKET 112
TABLE 53 COLOR ULTRASOUND DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 113
8.3 BLACK & WHITE ULTRASOUND DEVICES 113
8.3.1 ASIA PACIFIC REGION TO REGISTER SUSTAINED DEMAND FOR B/W ULTRASOUND DEVICES 113
TABLE 54 BLACK & WHITE ULTRASOUND DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 114
9 ULTRASOUND MARKET, BY APPLICATION 115
9.1 INTRODUCTION 116
TABLE 55 ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 116
9.2 RADIOLOGY/GENERAL IMAGING APPLICATIONS 116
9.2.1 GROWING NUMBER OF IMAGE-GUIDED SURGERIES/RADIOLOGY PROCEDURES TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 116
TABLE 56 ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 117
9.3 CARDIOLOGY APPLICATIONS 117
9.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 117
TABLE 57 ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 118
9.4 OBSTETRICS/GYNECOLOGY APPLICATIONS 118
9.4.1 ULTRASOUND IS WIDELY USED IN THE FIELD OF OBSTETRICS AND GYNECOLOGY 118
TABLE 58 ULTRASOUND MARKET FOR OBSTETRICS/GYNECOLOGY APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION) 119
9.5 VASCULAR APPLICATIONS 119
9.5.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 119
TABLE 59 ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 120
9.6 UROLOGICAL APPLICATIONS 120
9.6.1 ULTRASOUND IS WIDELY USED IN THE DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS 120
TABLE 60 ULTRASOUND MARKET FOR UROLOGICAL APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 121
9.7 ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS 121
9.7.1 RISING PATIENT PREFERENCE FOR EFFECTIVE & EARLY DISEASE DIAGNOSIS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 121
TABLE 61 ULTRASOUND MARKET FOR ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 122
9.8 PAIN MANAGEMENT APPLICATIONS 122
9.8.1 ULTRASOUND DEVICES ARE INCREASINGLY BEING UTILIZED FOR TRAUMA & EMERGENCY CARE APPLICATIONS 122
TABLE 62 ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 123
9.9 OTHER APPLICATIONS 123
TABLE 63 ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 123
10 ULTRASOUND MARKET, BY COMPONENT 124
10.1 INTRODUCTION 125
TABLE 64 ULTRASOUND MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 125
10.2 TRANSDUCERS/PROBES 125
TABLE 65 TRANSDUCERS/PROBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 66 TRANSDUCERS/PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 126
10.2.1 CURVILINEAR/CONVEX ARRAY PROBES 127
10.2.1.1 Growing adoption of POC ultrasound to drive the growth of this market segment 127
TABLE 67 CURVILINEAR/CONVEX ARRAY PROBES MARKET, BY REGION,
2019–2026 (USD MILLION) 127
10.2.2 LINER ARRAY PROBES 127
10.2.2.1 Increasing target patient population to drive the growth of this market segment 127
TABLE 68 LINEAR ARRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 128
10.2.3 PHASED ARRAY PROBES 128
10.2.3.1 Technological advancements to drive the growth of this market segment 128
TABLE 69 PHASED ARRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 128
10.2.4 OTHER PROBES 129
TABLE 70 OTHER PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 129
10.3 WORKSTATIONS 129
10.3.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 129
TABLE 71 WORKSTATIONS MARKET, BY REGION, 2019–2026 (USD MILLION) 130
10.4 OTHER COMPONENTS 130
TABLE 72 OTHER COMPONENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 130
11 ULTRASOUND MARKET, BY END USER 131
11.1 INTRODUCTION 132
TABLE 73 ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 132
11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS 132
11.2.1 SIGNIFICANT NUMBER OF ULTRASOUND-BASED MEDICAL PROCEDURES ARE PERFORMED IN THESE FACILITIES 132
TABLE 74 ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 2019–2026 (USD MILLION) 133
11.3 MATERNITY CENTERS 134
11.3.1 INCREASED ADOPTION OF ADVANCED 3D, 4D, AND DOPPLER ULTRASOUND FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH 134
TABLE 75 ULTRASOUND MARKET FOR MATERNITY CENTERS, BY REGION,
2019–2026 (USD MILLION) 134
11.4 AMBULATORY CARE CENTERS 135
11.4.1 GROWING NUMBER OF MINIMALLY INVASIVE PROCEDURES PERFORMED AT AMBULATORY CARE CENTERS TO DRIVE MARKET GROWTH 135
TABLE 76 ULTRASOUND MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2026 (USD MILLION) 135
11.5 RESEARCH AND ACADEMIA 136
11.5.1 GROWING RESEARCH GRANTS AND FUNDING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 136
TABLE 77 ULTRASOUND MARKET FOR RESEARCH AND ACADEMIA, BY REGION,
2019–2026 (USD MILLION) 136
11.6 OTHER END USERS 137
FIGURE 29 NUMBER OF SPORTS INJURIES (2020) 137
TABLE 78 ULTRASOUND MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION) 138

12 ULTRASOUND MARKET, BY REGION 139
12.1 INTRODUCTION 140
TABLE 79 ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 140
12.2 EUROPE 141
FIGURE 30 EUROPE: ULTRASOUND MARKET SNAPSHOT 141
TABLE 80 EUROPE: ULTRASOUND MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 81 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 142
TABLE 82 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 83 EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 84 EUROPE: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 143
TABLE 85 EUROPE: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 143
TABLE 86 EUROPE: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 144
TABLE 87 EUROPE: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 144
TABLE 88 EUROPE: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 89 EUROPE: ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 145
12.2.1 GERMANY 146
12.2.1.1 Wide acceptance of advanced technologies and favorable reimbursement scenario to drive market growth 146
TABLE 90 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 146
TABLE 91 GERMANY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 92 GERMANY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
12.2.2 UK 147
12.2.2.1 Rising geriatric population to drive market growth in the UK 147
TABLE 93 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 148
TABLE 94 UK: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 95 UK: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
12.2.3 FRANCE 149
12.2.3.1 Modernization of healthcare infrastructure fueling the demand for ultrasound systems 149
TABLE 96 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 150
TABLE 97 FRANCE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 98 FRANCE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
12.2.4 ITALY 151
12.2.4.1 Improved reimbursement scenario and increasing R&D to support overall market growth 151
TABLE 99 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 151
TABLE 100 ITALY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 101 ITALY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
12.2.5 SPAIN 152
12.2.5.1 Low entry barriers to create opportunities for global players to expand their presence in the country 152
TABLE 102 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 153
TABLE 103 SPAIN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 104 SPAIN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
12.2.6 REST OF EUROPE 154
TABLE 105 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 154
TABLE 106 REST OF EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 107 REST OF EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
12.3 NORTH AMERICA 156
TABLE 108 NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 156
TABLE 109 NORTH AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 156
TABLE 110 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 111 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 112 NORTH AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 157
TABLE 113 NORTH AMERICA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 158
TABLE 114 NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 158
TABLE 115 NORTH AMERICA: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 159
TABLE 116 NORTH AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 117 NORTH AMERICA: ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 160

12.3.1 US 160
12.3.1.1 The US dominated the North American ultrasound market 160
TABLE 118 POCUS ULTRASOUND CPT CODES (2021) 161
TABLE 119 CPT CODES FOR ULTRASOUND-GUIDED PROCEDURES (2021) 164
TABLE 120 US: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 165
TABLE 121 US: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 122 US: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
12.3.2 CANADA 166
12.3.2.1 Growing awareness about early disease diagnosis to drive market growth in Canada 166
TABLE 123 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 167
TABLE 124 CANADA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 125 CANADA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
12.4 ASIA PACIFIC 168
FIGURE 31 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT 169
TABLE 126 ASIA PACIFIC: ULTRASOUND MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 170
TABLE 127 ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 170
TABLE 128 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 129 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 130 ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 171
TABLE 131 ASIA PACIFIC: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 171
TABLE 132 ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 172
TABLE 133 ASIA PACIFIC: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 172
TABLE 134 ASIA PACIFIC: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 135 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 173
12.4.1 CHINA 174
12.4.1.1 Increasing patient pool and localized manufacturing to drive the market growth 174
TABLE 136 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 175
TABLE 137 CHINA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 138 CHINA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
12.4.2 JAPAN 176
12.4.2.1 Rising geriatric population to boost market growth in Japan 176
TABLE 139 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 176
TABLE 140 JAPAN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 141 JAPAN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
12.4.3 INDIA 177
12.4.3.1 Significant burden of target diseases and availability of affordable devices to drive market growth 177
TABLE 142 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 178
TABLE 143 INDIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 144 INDIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
12.4.4 SOUTH KOREA 179
12.4.4.1 Supportive government initiatives in the country to positively impact market growth 179
TABLE 145 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 180
TABLE 146 SOUTH KOREA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 147 SOUTH KOREA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
12.4.5 AUSTRALIA 181
12.4.5.1 Growing research investments and awareness campaigns to drive market growth in Australia 181
TABLE 148 AUSTRALIA: ULTRASOUND REIMBURSEMENT SCENARIO 181
TABLE 149 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 184
TABLE 150 AUSTRALIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 151 AUSTRALIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
12.4.6 REST OF ASIA PACIFIC 185
TABLE 152 ROAPAC: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 186
TABLE 153 ROAPAC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 154 ROAPAC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 186

12.5 LATIN AMERICA 187
TABLE 155 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 187
TABLE 156 LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 187
TABLE 157 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 158 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 159 LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 188
TABLE 160 LATIN AMERICA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 189
TABLE 161 LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 189
TABLE 162 LATIN AMERICA: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 190
TABLE 163 LATIN AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 164 LATIN AMERICA: ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 191
12.5.1 BRAZIL 191
12.5.1.1 Universal healthcare system to play a pivotal role in driving the use of ultrasound for disease diagnosis 191
TABLE 165 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 192
TABLE 166 BRAZIL: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 167 BRAZIL: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
12.5.2 MEXICO 193
12.5.2.1 Modernization of healthcare infrastructure to support market growth in Mexico 193
TABLE 168 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 193
TABLE 169 MEXICO: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 170 MEXICO: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
12.5.3 REST OF LATIN AMERICA 194
TABLE 171 ROLA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 195
TABLE 172 ROLA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 173 ROLA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 195

12.6 MIDDLE EAST & AFRICA 196
12.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA REGION 196
TABLE 174 MEA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 196
TABLE 175 MEA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 176 MEA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 177 MEA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 197
TABLE 178 MEA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 198
TABLE 179 MEA: ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 198
TABLE 180 MEA: ULTRASOUND MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 199
TABLE 181 MEA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 182 MEA: ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 200
13 COMPETITIVE LANDSCAPE 201
13.1 OVERVIEW 201
13.2 KEY PLAYER STRATEGIES 201
FIGURE 32 KEY DEVELOPMENTS IN THE ULTRASOUND MARKET (2018 TO 2021) 202
13.3 REVENUE SHARE ANALYSIS 203
FIGURE 33 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ULTRASOUND MARKET 203
13.4 MARKET SHARE ANALYSIS: ULTRASOUND MARKET, BY KEY PLAYER (2020) 204
FIGURE 34 GE HEALTHCARE HELD THE LEADING POSITION IN THE ULTRASOUND MARKET IN 2020 204
TABLE 183 ULTRASOUND MARKET: DEGREE OF COMPETITION 205
13.5 COMPANY EVALUATION QUADRANT FOR 25 KEY PLAYERS (2020) 206
13.5.1 TERMINOLOGY/NOMENCLATURE 206
13.5.1.1 Stars 206
13.5.1.2 Emerging leaders 206
13.5.1.3 Pervasive players 206
13.5.1.4 Participants 206
FIGURE 35 ULTRASOUND MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 207
13.6 COMPANY EVALUATION QUADRANT FOR START-UP/SMES (2020) 208
13.6.1 PROGRESSIVE COMPANIES 208
13.6.2 RESPONSIVE COMPANIES 208
13.6.3 DYNAMIC COMPANIES 208
13.6.4 STARTING BLOCKS 208
FIGURE 36 ULTRASOUND MARKET: COMPETITIVE LEADERSHIP MAPPING
(SME/START-UPS) 209
13.7 COMPETITIVE BENCHMARKING 210
TABLE 184 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN
THE ULTRASOUND MARKET 210
13.8 COMPETITIVE SCENARIO (2018–2021) 210
13.8.1 NEW PRODUCT LAUNCHES AND APPROVALS 210
TABLE 185 ULTRASOUND MARKET: NEW PRODUCT LAUNCHES AND APPROVALS,
2018–2021 210
13.8.2 DEALS 211
TABLE 186 ULTRASOUND MARKET: DEALS, 2018–2021 211
13.8.3 EXPANSIONS 212
TABLE 187 ULTRASOUND MARKET: EXPANSIONS, 2018–2021 212
14 COMPANY PROFILES 213
14.1 INTRODUCTION 213
14.2 KEY PLAYERS 214
(Business overview, Products offered, Recent developments, MNM view)*
14.2.1 GE HEALTHCARE 214
TABLE 188 GE HEALTHCARE: BUSINESS OVERVIEW 214
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2020) 215
14.2.2 KONINKLIJKE PHILIPS N.V. 219
TABLE 189 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 219
FIGURE 38 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 220
14.2.3 CANON MEDICAL SYSTEMS CORPORATION 224
TABLE 190 CANON MEDICAL SYSTEMS CORPORATION: BUSINESS OVERVIEW 224
FIGURE 39 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2020) 225
14.2.4 SIEMENS AG 228
TABLE 191 SIEMENS AG: BUSINESS OVERVIEW 228
FIGURE 40 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 229
14.2.5 HITACHI, LTD. 232
TABLE 192 HITACHI, LTD.: BUSINESS OVERVIEW 232
FIGURE 41 HITACHI, LTD.: COMPANY SNAPSHOT 233
14.2.6 HOLOGIC, INC. 236
TABLE 193 HOLOGIC, INC.: BUSINESS OVERVIEW 236
FIGURE 42 HOLOGIC, INC.: COMPANY SNAPSHOT 237
14.2.7 FUJIFILM HOLDINGS CORPORATION 239
TABLE 194 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 239
FIGURE 43 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 240
14.2.8 SAMSUNG ELECTRONICS CO., LTD. 243
TABLE 195 SAMSUNG ELECTRONICS CO., LTD.: BUSINESS OVERVIEW 243
FIGURE 44 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT 244
14.2.9 MINDRAY MEDICAL INTERNATIONAL LIMITED 247
TABLE 196 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 247
FIGURE 45 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT 247
14.2.10 ANALOGIC CORPORATION 250
TABLE 197 ANALOGIC CORPORATION: BUSINESS OVERVIEW 250
14.2.11 ESAOTE SPA 252
TABLE 198 ESAOTE S.P.A: BUSINESS OVERVIEW 252
14.2.12 CARESTREAM HEALTH 255
TABLE 199 CARESTREAM HEALTH: BUSINESS OVERVIEW 255
FIGURE 46 ONEX CORPORATION: COMPANY SNAPSHOT 255
14.2.13 CURA HEALTHCARE 257
TABLE 200 CURA HEALTHCARE: BUSINESS OVERVIEW 257
14.2.14 CHISON MEDICAL TECHNOLOGIES CO., LTD. 258
TABLE 201 CHISON MEDICAL TECHNOLOGIES CO., LTD.: BUSINESS OVERVIEW 258
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
14.3 OTHER COMPANIES 260
14.3.1 MOBISANTE, INC. 260
14.3.2 NEUSOFT CORPORATION 261
14.3.3 CLARIUS MOBILE HEALTH 262
14.3.4 MEDGYN PRODUCTS, INC. 262
14.3.5 UNITED IMAGING HEALTHCARE CO., LTD. 263
14.3.6 PROMED TECHNOLOGY CO., LTD. 264
14.3.7 CEPHASONICS 265
14.3.8 UAB TELEMED 265
14.3.9 SHENZHEN RICSO TECHNOLOGY CO., LTD. 266
14.3.10 WUHAN YOUKEY BIO-MEDICAL ELECTRONICS CO., LTD. 267
15 APPENDIX 268
15.1 DISCUSSION GUIDE 268
15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 273
15.3 AVAILABLE CUSTOMIZATIONS 275
15.4 RELATED REPORTS 276
15.5 AUTHOR DETAILS 277


お問合せフォーム

    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com